André Kobelt
Directeur Général chez Heraeus Deutschland GmbH & Co. KG
Profil
André Kobelt is currently the Co-Managing Director at Heraeus Deutschland GmbH & Co. KG, the Director at mimiX Biotherapeutics Ltd., and the Chief Operating Officer at Heraeus Holding GmbH.
Postes actifs de André Kobelt
| Sociétés | Poste | Début |
|---|---|---|
Heraeus Deutschland GmbH & Co. KG
 Heraeus Deutschland GmbH & Co. KG Other Metals/MineralsNon-Energy Minerals Heraeus Deutschland GmbH & Co. KG engages in the development and production of materials for the assembly and packaging of devices in the electronics industry. It offers material solutions for consumer electronics, information technology, automotive, power electronics, and communications sectors. The firm specializes in bonding wires, adhesives, solder materials, sinter materials, thick film pastes, as well as metal and metal ceramic substrates. The company was founded by Wilhelm Carl Heraeus in 1851 and is headquartered in Hanau, Germany. | Directeur Général | - |
Heraeus Holding GmbH
 Heraeus Holding GmbH Wholesale DistributorsDistribution Services Heraeus Holding GmbH operates as a technology company. It focuses on the environmental, energy, electronics, health, mobility and industrial applications sectors. The company was founded by Willhelm Carl Heraeus in 1851 and is headquartered in Hanau, Germany. | Directeur des opérations | 01/01/2016 |
Mimix Biotherapeutics Sàrl
 Mimix Biotherapeutics Sàrl BiotechnologyHealth Technology Mimix Biotherapeutics Sàrl is a private company located in Switzerland that develops and commercializes a platform to overcome limitations in tissue engineering, specifically the vascularization challenge and the need for high cell quantities. The Swiss company creates biological architectures with sound using sound-induced morphogenesis, which is a gentle, fast, and easy method to generate multi-cellular, spatially orchestrated tissue constructs using sound waves. The company offers guides for patterning parameters and cells in various hydrogels, including collagen, fibrin, gelatine, and synthetic hydrogels. The company's FastSkin® technology combines micrografting with sound-induced morphogenesis to improve wound care management, addressing a major social burden and unmet clinical need in oncology and chronic wounds treatments. Mimix Biotherapeutics also provides control over cellular and extracellular organization at high spatial resolution to investigate cell-material interactions in vitro models. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Heraeus Deutschland GmbH & Co. KG
Heraeus Deutschland GmbH & Co. KG Other Metals/MineralsNon-Energy Minerals Heraeus Deutschland GmbH & Co. KG engages in the development and production of materials for the assembly and packaging of devices in the electronics industry. It offers material solutions for consumer electronics, information technology, automotive, power electronics, and communications sectors. The firm specializes in bonding wires, adhesives, solder materials, sinter materials, thick film pastes, as well as metal and metal ceramic substrates. The company was founded by Wilhelm Carl Heraeus in 1851 and is headquartered in Hanau, Germany. | Non-Energy Minerals |
Heraeus Holding GmbH
Heraeus Holding GmbH Wholesale DistributorsDistribution Services Heraeus Holding GmbH operates as a technology company. It focuses on the environmental, energy, electronics, health, mobility and industrial applications sectors. The company was founded by Willhelm Carl Heraeus in 1851 and is headquartered in Hanau, Germany. | Distribution Services |
Mimix Biotherapeutics Sàrl
Mimix Biotherapeutics Sàrl BiotechnologyHealth Technology Mimix Biotherapeutics Sàrl is a private company located in Switzerland that develops and commercializes a platform to overcome limitations in tissue engineering, specifically the vascularization challenge and the need for high cell quantities. The Swiss company creates biological architectures with sound using sound-induced morphogenesis, which is a gentle, fast, and easy method to generate multi-cellular, spatially orchestrated tissue constructs using sound waves. The company offers guides for patterning parameters and cells in various hydrogels, including collagen, fibrin, gelatine, and synthetic hydrogels. The company's FastSkin® technology combines micrografting with sound-induced morphogenesis to improve wound care management, addressing a major social burden and unmet clinical need in oncology and chronic wounds treatments. Mimix Biotherapeutics also provides control over cellular and extracellular organization at high spatial resolution to investigate cell-material interactions in vitro models. | Health Technology |
